Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Johannesson

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Circulation|January 1, 1994
Low iron-binding capacity as a risk factor for myocardial infarctionM K Magnusson, N Sigfusson, H Sigvaldason, et al.
European Heart Journal|July 1, 1996
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)B Jönsson, M Johannesson, J Kjekshus, et al.
The New England Journal of Medicine|January 30, 1997
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study GroupM Johannesson, B Jönsson, J Kjekshus, et al.
Clinical Genetics|January 15, 2000
Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in SwedenC Schaedel, L Hjelte, I de Monestrol, et al.
Stem Cells (Dayton, Ohio)|November 6, 2009
FGF2 specifies hESC-derived definitive endoderm into foregut/midgut cell lineages in a concentration-dependent mannerJacqueline Ameri, Anders Ståhlberg, Jesper Pedersen, et al.
Microscopy Research and Technique|April 6, 2006
Composition of nasal airway surface liquid in cystic fibrosis and other airway diseases determined by X-ray microanalysisV Vanthanouvong, I Kozlova, M Johannesson, et al.
Health Policy (Amsterdam, Netherlands)|March 8, 1997
Patients' willingness to pay for autologous blood donationS J Lee, P J Neumann, W H Churchill, et al.
The European Respiratory Journal|August 9, 2002
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosisW Zetterquist, H Marteus, M Johannesson, et al.
Health Policy (Amsterdam, Netherlands)|July 6, 1997
The cost-effectiveness of a cardiovascular risk reduction program in general practiceG Salkeld, P Phongsavan, B Oldenburg, et al.
Pediatric Pulmonology|May 10, 2002
Predictors of deterioration of lung function in cystic fibrosisC Schaedel, I de Monestrol, L Hjelte, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Circulation|January 1, 1994
Low iron-binding capacity as a risk factor for myocardial infarctionM K Magnusson, N Sigfusson, H Sigvaldason, et al.
European Heart Journal|July 1, 1996
Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)B Jönsson, M Johannesson, J Kjekshus, et al.
The New England Journal of Medicine|January 30, 1997
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study GroupM Johannesson, B Jönsson, J Kjekshus, et al.
Clinical Genetics|January 15, 2000
Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in SwedenC Schaedel, L Hjelte, I de Monestrol, et al.
Stem Cells (Dayton, Ohio)|November 6, 2009
FGF2 specifies hESC-derived definitive endoderm into foregut/midgut cell lineages in a concentration-dependent mannerJacqueline Ameri, Anders Ståhlberg, Jesper Pedersen, et al.
Microscopy Research and Technique|April 6, 2006
Composition of nasal airway surface liquid in cystic fibrosis and other airway diseases determined by X-ray microanalysisV Vanthanouvong, I Kozlova, M Johannesson, et al.
Health Policy (Amsterdam, Netherlands)|March 8, 1997
Patients' willingness to pay for autologous blood donationS J Lee, P J Neumann, W H Churchill, et al.
The European Respiratory Journal|August 9, 2002
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosisW Zetterquist, H Marteus, M Johannesson, et al.
Health Policy (Amsterdam, Netherlands)|July 6, 1997
The cost-effectiveness of a cardiovascular risk reduction program in general practiceG Salkeld, P Phongsavan, B Oldenburg, et al.
Pediatric Pulmonology|May 10, 2002
Predictors of deterioration of lung function in cystic fibrosisC Schaedel, I de Monestrol, L Hjelte, et al.
Pageof 16